WO2025215515 - SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS
National phase entry is expected:
Publication Number
WO/2025/215515
Publication Date
16.10.2025
International Application No.
PCT/IB2025/053672
International Filing Date
07.04.2025
Title **
[English]
SYSTEMS AND METHODS FOR GENERATION OF HYPERPOLARIZED MATERIALS
[French]
SYSTÈMES ET PROCÉDÉS DE GÉNÉRATION DE MATÉRIAUX HYPERPOLARISÉS
Applicants **
NVISION IMAGING TECHNOLOGIES GMBH
Inventors
SCHWARTZ, Ilai
KEIM, Michael
RÖSLER, Lorenz
GIERSE, Martin
KNECHT, Stephan
Priority Data
63/631,096
08.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4750 | |
| EPO | Filing, Examination, Granting | 81031 | |
| Japan | Filing, Examination, Granting | 4528 | |
| South Korea | Filing, Examination, Granting | 6889 | |
| USA | Filing, Examination, Granting | 19140 |
Total:
116,338
Contact Us
Abstract[English]
The disclosed embodiments include systems and methods for producing hyperpolarized molecules of interest (such as hyperpolarized biorelevant imaging agents), in clinically relevant polarizations, concentrations, volumes, and purity. Disclosed embodiments provide technical improvements in polarizing molecules of interest in solution. These technical improvements support increases in molecule of interest concentration and the degree of polarization.[French]
Les modes de réalisation de l'invention comprennent des systèmes et des procédés de production de molécules d'intérêt hyperpolarisées (telles que des agents d'imagerie biopertinents hyperpolarisés), dans des polarisations, des concentrations, des volumes et une pureté cliniquement pertinents. Des modes de réalisation de l'invention concernent des améliorations techniques dans des molécules polarisantes d'intérêt en solution. Ces améliorations techniques prennent en charge des augmentations de la concentration de molécules d'intérêt et du degré de polarisation.